European Commission vs Big Pharma, or profit vs access?
Drug Discovery World
MARCH 29, 2023
What of the increased possibilities for ‘replacement pharmacy compounding’ for weekly hospital supplies, and for routine manufacturing of cell and gene therapies without a marketing authorisation? He pointed out that Europe was the first region to approve biosimilars. You can compare timelines.
Let's personalize your content